FDA labeling of NSAIDs: Review of nonsteroidal anti-inflammatory drugs in cardiovascular disease

详细信息    查看全文

• 作者：Preethi Pirlamarla ; MD^a ; Rachel M. Bond ; MD ; FACC^b ; ^{rbond12@northwell.edu" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Nonsteroidal anti-inflammatory drugs ; Cardiovascular disease ; Coronary artery disease ; Cardiovascular risk ; Rheumatologic disease ; COX-2 inhibitors ; Nonselective NSAIDs
• 刊名：Trends in Cardiovascular Medicine
• 出版年：2016
• 出版时间：November 2016
• 年：2016
• 卷：26
• 期：8
• 页码：675-680
• 全文大小：392 K

文摘

Nonsteroidal anti-inflammatory drugs (NSAIDs) have been extensively used worldwide for both chronic and acute musculoskeletal and inflammatory conditions. Extensive evidence has linked NSAID use with adverse cardiovascular events. This review article aims to review the existing evidence on the risk of cardiovascular and coronary events in both selective and nonselective NSAIDs, the time course of NSAIDs associated with cardiovascular risk, and specific populations that may be at increased risk.